GeneYX
Founded 2018 · 30 employees on LinkedIn · 1 known investors
Find your way into GeneYX
1 people in our graph share verified history with the GeneYX team — schools, employers, funds. One of them is your warm intro.
Geneyx offers a genomic data analysis platform for secondary and tertiary interpretation of NGS data, including exome, whole genome sequencing, and gene panels, with AI/ML-driven variant interpretation, automated annotation, and customizable reporting. It serves genetics labs, life-science companies, clinical researchers, and research institutes worldwide, integrating with LIMS and existing bioinformatic pipelines.
Founders & leadership
GeneYX was founded in 2018 by David Yizhar.
DY
David YizharinCo-Founder and CEODavid Yizhar founded and led diagnostic and medical device companies for over 40 years across Israel, Eastern Europe, Italy, and the Far East, with a focus on molecular biology and NGS over the past decade; he holds a B.A. and MBA from Hebrew University of Jerusalem and is co-founder and CEO of GeneYX, which provides AI-driven genomic data interpretation for clinical labs and research institutions.
Investors · 1
Frequently asked questions
- What does GeneYX do?
- Geneyx offers a genomic data analysis platform for secondary and tertiary interpretation of NGS data, including exome, whole genome sequencing, and gene panels, with AI/ML-driven variant interpretation, automated annotation, and customizable reporting. It serves genetics labs, life-science companies, clinical researchers, and research institutes worldwide, integrating with LIMS and existing bioinformatic pipelines.
- Who founded GeneYX?
- GeneYX was founded by David Yizhar in 2018.
- Who are GeneYX's investors?
- GeneYX's investors include NextLeap Ventures.